Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantation.
Holler
E
E
Med Klinik III, Klinikum Grosshadern, Univ München, Germany.
Kolb
H J
HJ
Hintermeier-Knabe
R
R
Mittermüller
J
J
Thierfelder
S
S
Kaul
M
M
Wilmanns
W
W
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use / Q000633:toxicity*; D015415:Biomarkers / Q000097:blood; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D006086:Graft vs Host Disease / Q000276:immunology / Q000628:therapy*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery; D051379:Mice; D008815:Mice, Inbred Strains; D009190:Myelodysplastic Syndromes / Q000601:surgery; D010865:Pilot Projects; D016019:Survival Analysis; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000276:immunology*
D000906:Antibodies; D000911:Antibodies, Monoclonal; D015415:Biomarkers; D014409:Tumor Necrosis Factor-alpha